1. What Is the Diabetes Management Software Market?
The Diabetes Management Software Market encompasses digital platforms, mobile applications, and clinical decision tools that collect, analyse, and display diabetes-related data to help patients and clinicians manage blood glucose levels, medication adherence, and lifestyle factors. The market includes ambulatory glucose profile software for CGM data analysis, insulin dosing decision algorithms, diabetes self-management mobile apps, electronic health record-integrated diabetes modules, and predictive glycaemic analytics tools for endocrinology clinical programmes. These platforms are used by people with type 1 and type 2 diabetes for self-management guidance. They are also used by endocrinologists, diabetes nurse specialists, and care teams for remote data review, treatment optimisation, and patient engagement between clinic visits. Market scope covers software platforms and applications for diabetes data management and clinical decision support. It excludes hardware continuous glucose monitor devices, insulin pumps, and glucose meters without embedded software, and general chronic disease management platforms not designed specifically for diabetes.
2. Diabetes Management Software Market Size & Forecast
3. Emerging Technologies
- Large language model integration in diabetes management software is advancing conversational AI interfaces that answer patient questions about carbohydrate counting, dose adjustment, and glucose pattern interpretation from natural. Growing diabetes app developer interest in.
- FHIR-based interoperability integration is advancing standardised data exchange connections between diabetes management software platforms and hospital EHR systems, enabling automatic upload of CGM, insulin, and glucose data to the patient's primary care record without. Growing industry adoption of this technology is motivating development.
- Population-level diabetes data analytics platforms are advancing cloud-based aggregated CGM and clinical data visualisation tools that enable endocrinology and primary care programme directors. Growing industry adoption of this technology is motivating development.
- Reinforcement learning glucose prediction modelling is advancing machine learning models trained on individual patient CGM data streams that predict future glucose trajectories to 30 to 60 minutes, providing early warning of predicted hypoglycaemia and. Growing industry adoption of this technology is motivating development.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Connected Diabetes Device Market.
4. Key Market Opportunity
A major opportunity in the Diabetes Management Software Market is the integration of AI-powered insulin dosing guidance and CGM data analytics into primary care EHR platforms, enabling generalist physicians to manage type 2 diabetes with specialist-quality data insight. A significant proportion of type 2 diabetes patients managed in primary care receive suboptimal glycaemic control due to clinician time constraints, limited CGM data interpretation capability, and absence of automated insulin titration tools in primary care EHR systems. AI-powered diabetes management software modules embedded in primary care EHR workflows that automate CGM data interpretation and recommend insulin dose adjustments enable generalist physicians to achieve specialist-quality diabetes management outcomes. Diabetes software developers that achieve primary care EHR integration with validated AI insulin dosing modules, demonstrate glycaemic control improvement in primary care populations, and establish value-based payer contracts are positioned to capture the large primary care diabetes management market.
5. Top Companies in the Diabetes Management Software Market
The following organisations hold leading positions in the Diabetes Management Software Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Dexcom (Clarity)
- Abbott (LibreView)
- Sanofi (MyDose Coach)
- Novo Nordisk (NovoPen App)
- Roche Diabetes Care
- Medtronic (CareLink)
- Glooko
- Tidepool
- mySugr (Roche)
- Teladoc Health (Livongo)
6. Market Segmentation
The Diabetes Management Software Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Solution Type | Ambulatory Glucose Profile Software CGM Data Viewer AGP Report Generator Insulin Dosing Algorithm Bolus Calculator App Basal Titration Tool Diabetes Self-Management App Patient-Facing Glucose App Carbohydrate Counting App Clinical Decision Platform Endocrinology EHR Module Remote Monitoring Dashboard Predictive Analytics Tool Hypoglycaemia Prediction Glycaemic Variability Analytics |
| By Diabetes Type | Type 1 Diabetes T1D Closed-Loop Integration T1D CGM Management Type 2 Diabetes T2D Self-Management App T2D Basal Titration Gestational Diabetes GDM Glucose Tracking App Pre-Diabetes Pre-Diabetes Lifestyle App |
| By Deployment | Cloud-Based SaaS Multi-Tenant Cloud Platform On-Premise Hospital Data Centre Hosted Mobile App iOS and Android App Wearable-Integrated CGM-Synced Software |
| By End User | Patients Diabetes Self-Managers Endocrinologists Specialist Diabetes Clinics Primary Care Physicians GP Diabetes Management Healthcare Systems Hospital Diabetes Programme Payers Value-Based Diabetes Programme |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Diabetes Management Software Market trajectory over the forecast period:
Ambulatory Glucose Profile Software Is Standardising CGM Data Review and Improving Clinical Communication Between Patients and Diabetes Care Teams.Endocrinologists and diabetes nurse specialists reviewing CGM data are adopting ambulatory glucose profile software that converts raw CGM sensor data into standardised time-in-range, glucose management indicator, and glucose variability reports enabling consistent clinical interpretation. Dexcom and Abbott continued development of Clarity and LibreView CGM data management platforms with updated ambulatory glucose profile visualisation and remote care team access in 2024. This provides diabetes care teams with standardised CGM report formats for clinical review.
AI-Driven Insulin Dosing Algorithms Are Improving Glycaemic Outcomes for Type 2 Diabetes Patients on Basal Insulin by Automating Titration Guidance.Primary care physicians and endocrinologists managing type 2 diabetes patients initiating basal insulin are prescribing automated titration apps that calculate the next basal insulin dose from patient-entered fasting glucose readings, reducing clinician workload. This achievs target fasting glucose faster than manual titration. Sanofi continued commercial development and prescribing expansion of the MyDose Coach app for basal insulin titration in type 2 diabetes in 2024. This provides primary care physicians with an automated titration solution that guides patients to target fasting glucose without requiring frequent clinician dose calculation calls.
Predictive Hypoglycaemia Alerts from CGM-Integrated Software Are Reducing Nocturnal Hypoglycaemia Frequency in Type 1 Diabetes.Endocrinologists managing type 1 diabetes patients on multiple daily injections are prescribing CGM-integrated predictive alert software that identifies the downward glucose trend rate required to predict imminent hypoglycaemia. Provides advance warning 20 to 30 minutes before the event. Dexcom and Abbott continued development of predictive low glucose alert algorithms integrated into their CGM companion app ecosystems in 2024. Growing type 1 diabetes patient adoption of predictive alerts as published evidence demonstrates hypoglycaemia frequency reduction compared with threshold-only alarms.
For related market intelligence, see the Diabetes Care Platform Market.
8. Segmental Analysis
By solution type, ambulatory glucose profile software dominated the Diabetes Management Software Market in 2025, driven by the growing CGM user base requiring standardised data management for clinical review. Endocrinologists and diabetes care teams continue specifying CGM data management software as the primary diabetes digital tool as AGP reports enable consistent CGM interpretation and remote data review between clinic visits. AI-powered insulin dosing algorithms are the fastest-growing solution type, driven by growing type 2 diabetes programme adoption of automated basal insulin titration apps. Primary care physicians are increasing automated insulin titration app prescribing as evidence demonstrates faster attainment of target fasting glucose and reduced physician workload versus manual dose adjustment protocols.
By diabetes type, type 2 diabetes dominated the Diabetes Management Software Market in 2025, driven by the large global patient population and primary care adoption of self-management apps and insulin titration software. Endocrinologists and primary care physicians managing the large type 2 diabetes population continue generating the highest diabetes software demand as growing CGM adoption and insulin therapy complexity create demand for digital tools. Type 1 diabetes is the fastest-growing segment, driven by CGM and closed-loop insulin pump adoption creating demand for advanced software platforms integrating CGM data, insulin records, and predictive glucose analytics. People with type 1 diabetes are increasing adoption of advanced CGM software and closed-loop integration platforms as validated closed-loop system outcomes evidence drives automated insulin delivery adoption.
9. Regional Analysis
Regional demand patterns across the Diabetes Management Software Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Diabetes Management Software Market in 2025, with a market share of 42.0%. The region's leadership reflects the large type 1 and type 2 diabetes patient population in the United States and Canada generating demand for CGM data management and insulin dosing software, strong health information technology investment at United States endocrinology and primary care programmes, and the concentration of diabetes software developers with North American commercial headquarters. Comprehensive United States private and Medicare Part D coverage for CGM devices and associated data management software creates consistent demand for ambulatory glucose profile software and connected insulin dosing applications at diabetes care programmes. Growing United States digital health investment and FDA regulatory pathway development for software-based clinical decision tools are accelerating diabetes management software approval and commercial adoption at endocrinology and primary care practices.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 14.60% during the forecast period. Growing type 2 diabetes prevalence in China, India, Japan, South Korea, and Southeast Asia, expanding smartphone penetration enabling mobile diabetes app adoption, and increasing government digital health investment are creating demand for diabetes management software across the region. Growing Chinese government investment in digital health infrastructure and diabetes prevention programmes is creating demand for diabetes management software platforms at hospital endocrinology departments and community health centre diabetes management programmes. Growing Japanese and South Korean endocrinology programme adoption of CGM data management software and ambulatory glucose profile tools is creating demand for advanced diabetes analytics platforms at specialist diabetes care centres managing growing type 1 and type 2 patient populations.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Diabetes Management Software Market was valued at USD 2.81 Bn in 2025 and is projected to reach USD 7.92 Bn by 2034, growing at a CAGR of 12.20% over the 2026–2034 forecast period.
The Diabetes Management Software Market is projected to grow at a CAGR of 12.20% from 2026 to 2034.
North America dominated the Diabetes Management Software Market in 2025, with a market share of 42.0%.
The leading companies in the Diabetes Management Software Market include Dexcom (Clarity), Abbott (LibreView), Sanofi (MyDose Coach), Novo Nordisk (NovoPen App), Roche Diabetes Care, Medtronic (CareLink), Glooko, Tidepool, mySugr (Roche), Teladoc Health (Livongo).
Ambulatory glucose profile software is standardising cgm data review and improving clinical communication between patients and diabetes care teams.
By solution type, ambulatory glucose profile software dominated the Diabetes Management Software Market in 2025, driven by the growing CGM user base requiring standardised data management for clinical review.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.